Company
Cara Therapeutics
Cara Therapeutics has 5 drugs tracked on RxWires: 3 in Phase 3, 1 in Phase 2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CR845 | Phase 3 | Uremic Pruritus |
| Difelikefalin 1 mg Oral Tablet | Phase 3 | Chronic Kidney Diseases |
| CR845 0.5 mcg/kg | Phase 3 | Uremic Pruritus |
| Part A: CR845 0.5 mcg/kg | Phase 2 | Pruritus |
| [14C] CR845 | Phase 1 | Hemodialysis |
Latest
No recent events.
Follow Cara Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.